This PPT gives the idea about importance of audit. Every QA personnel should aware about the fact behind every aspects of audit. This PPT is useful for all auditor in pharmaceutical domain.
WHO Good Manufacturing Practice Requirements
Good Manufacturing Practice is the part of quality assurance that ensures that products are consistently manufactured and controlled to the quality standards appropriate to their intended use.
It is process of “Establishing documentary evidence that provide a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes”.
In the pharmaceutical industry, it is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results.
Validation is action of proving in accordance with the principles of good manufacturing practices, that any procedure, process, equipment, material, activity or system actually leads to expected results.
Cleaning validation is documented evidence with a high degree assurance that one can consistently clean a system or a piece of equipment to predetermined and acceptable limits.
The primary regulatory concern driving the need for cleaning validation is cross contamination of the desired drug substance either by other API from previous batch runs or by residues from the cleaning agents used.
The prime purpose of validating a cleaning process is to ensure compliance with federal and other standard regulations
1. Cross contamination with active ingredients
Contamination of one batch of product with significant levels of residual active ingredients from previous batch cannot be tolerated.
In addition to the obvious problems posed by subjecting consumers or patients to unintended contaminants, potential clinically significant synergistic interactions between pharmacologically active chemicals are a real concern.
2. Contamination with unintended materials or compounds
While inert ingredients used in drug products are generally recognized as safe for human consumption, the routine use, maintenance and cleaning of equipment's provide the potential contamination with such items as equipment parts, lubricants and chemical cleaning agents3. Microbiological contamination
Maintenance , cleaning and storage conditions may provide adventitious microorganisms with the opportunity to proliferate within the processing equipment.
WHO Good Manufacturing Practice Requirements
Good Manufacturing Practice is the part of quality assurance that ensures that products are consistently manufactured and controlled to the quality standards appropriate to their intended use.
It is process of “Establishing documentary evidence that provide a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes”.
In the pharmaceutical industry, it is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results.
Validation is action of proving in accordance with the principles of good manufacturing practices, that any procedure, process, equipment, material, activity or system actually leads to expected results.
Cleaning validation is documented evidence with a high degree assurance that one can consistently clean a system or a piece of equipment to predetermined and acceptable limits.
The primary regulatory concern driving the need for cleaning validation is cross contamination of the desired drug substance either by other API from previous batch runs or by residues from the cleaning agents used.
The prime purpose of validating a cleaning process is to ensure compliance with federal and other standard regulations
1. Cross contamination with active ingredients
Contamination of one batch of product with significant levels of residual active ingredients from previous batch cannot be tolerated.
In addition to the obvious problems posed by subjecting consumers or patients to unintended contaminants, potential clinically significant synergistic interactions between pharmacologically active chemicals are a real concern.
2. Contamination with unintended materials or compounds
While inert ingredients used in drug products are generally recognized as safe for human consumption, the routine use, maintenance and cleaning of equipment's provide the potential contamination with such items as equipment parts, lubricants and chemical cleaning agents3. Microbiological contamination
Maintenance , cleaning and storage conditions may provide adventitious microorganisms with the opportunity to proliferate within the processing equipment.
What is 21 CFR Part 11?:
21 CFR Part 11:
Allow the industry to use electronic records and signatures alternatively to paper records and hand-written signatures
21 CFR Part 11 applies:
To all FDA regulated environments
When using computers in the creation, modification, archiving, retrieval or transmission of data or records
To records required by predicate rules – GLP, GCP, GMP – that impact patient safety
To new and old systems
Purpose of Part 11
Ensure data is not corrupted or lost
Data is secure
Approvals cannot be repudiated
Changes to data can be traced
Attempts to falsify records are made difficult and can be detected
Types of Systems
Two types of systems that come under 21 CFR Part 11 – closed and open systems
Closed and Open Systems:
What is a Closed system?
A system to which access is controlled by person responsible for electronic records stored on it
What is an Open system?
A system to which access is not controlled by those responsible for the electronic records stored on it
21 CFR Part 11 Requirements:
21 CFR Part 11 lists the following controls for closed systems:
Validation
Device checks
Operational system checks
Accurate and complete copies
Accurate and steady retrieval
Limited access to systems and data
Authority checks
Electronic audit trail
Training/qualification of personnel
Accountability of signatures
Control over system documentation
Digital Signatures :
Use of digital signatures for open systems
Electronic Signatures
Requirements for signed electronic records
Linking records to signatures
This presentation describes approaches for software validation used to automate laboratory research procedures, consolidate data collection and analysis and/or run sophisticated QC or manufacturing operations.
Several approaches to software validation exist and may be appropriate for a specific project.
The scope of any validation effort depends upon a number of factors
Size and complexity of the software,
Origin of the software (custom vs. off-the-shelf) and
Whether the functions are critical or non-critical in nature.
By effectively planning the process, validation time and resources can be reduced while meeting regulatory requirements.
Validation: Validation is a documented program that provides high degree of assurance that a specific process, method or system consistently produces a result meeting pre-determined acceptance criteria.
What is 21 CFR Part 11?:
21 CFR Part 11:
Allow the industry to use electronic records and signatures alternatively to paper records and hand-written signatures
21 CFR Part 11 applies:
To all FDA regulated environments
When using computers in the creation, modification, archiving, retrieval or transmission of data or records
To records required by predicate rules – GLP, GCP, GMP – that impact patient safety
To new and old systems
Purpose of Part 11
Ensure data is not corrupted or lost
Data is secure
Approvals cannot be repudiated
Changes to data can be traced
Attempts to falsify records are made difficult and can be detected
Types of Systems
Two types of systems that come under 21 CFR Part 11 – closed and open systems
Closed and Open Systems:
What is a Closed system?
A system to which access is controlled by person responsible for electronic records stored on it
What is an Open system?
A system to which access is not controlled by those responsible for the electronic records stored on it
21 CFR Part 11 Requirements:
21 CFR Part 11 lists the following controls for closed systems:
Validation
Device checks
Operational system checks
Accurate and complete copies
Accurate and steady retrieval
Limited access to systems and data
Authority checks
Electronic audit trail
Training/qualification of personnel
Accountability of signatures
Control over system documentation
Digital Signatures :
Use of digital signatures for open systems
Electronic Signatures
Requirements for signed electronic records
Linking records to signatures
This presentation describes approaches for software validation used to automate laboratory research procedures, consolidate data collection and analysis and/or run sophisticated QC or manufacturing operations.
Several approaches to software validation exist and may be appropriate for a specific project.
The scope of any validation effort depends upon a number of factors
Size and complexity of the software,
Origin of the software (custom vs. off-the-shelf) and
Whether the functions are critical or non-critical in nature.
By effectively planning the process, validation time and resources can be reduced while meeting regulatory requirements.
Validation: Validation is a documented program that provides high degree of assurance that a specific process, method or system consistently produces a result meeting pre-determined acceptance criteria.
Internal Audit Best Practices for Safety, Environment, and Quality AuditsNimonik
Nimonik has seen a wide variety of internal Health, Safety, Environmental and Quality (HSEQ) audit programs. They seem to come in all shapes and sizes! Each company tends to focus on different risks and controls.
Whether your organization conforms to ISO 19011 or another internal audit standard, re-focusing your internal audit program on your risks, controls, and operational reality is a key driver for operational excellence.
On March 14th, John Wolfe shared insights from over 20 years as a hands-on HSE Director and as the Sr. Director of Operations Integrity Audit for a global Oil & Gas company. John outlined the attributes of an outstanding Internal audit program. He showed you how you can build out a program tailored to your operations and add tremendous value to your business.
42 pages editable MS Word document with detailed explanations, auditor tips and recommendations - our ISO 45001 Audit checklist can be utilized in a number of ways. The ISO 45001:2018 Audit checklist:
- provides a complete understanding of how to verify compliance with the requirements of all ISO 45001:2018 clauses;
- can be used as practice for internal auditors workshops.
- allows every employee to check his/her activity performance in compliance with the new requirements of ISO 45001:2018 and more.
PECB Webinar: Overview of ISO 13485 - Medical DevicesPECB
The webinar covers:
• The key section of ISO 13485
• The benefits of ISO 13485
• In brief how ISO 13485 & ISO 9001 correlate
Presenter:
This webinar was presented by Raza Shah, Chief Editor and Owner of Bitehqeeq.
Link of the recorded session published on YouTube: https://youtu.be/gZlhUlqgo1g
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Critical aspects during audit (BA/BE)
1. Prepared By:
Piyush V. Wagh
Senior Executive
Quality Assurance Department
Date: 30th Aug 18
Ref: image downloaded from presenter media
1
2. Critical Aspects During Audit (BABE)
What is Quality?
Quality can be say as:
The standard of something as measured against
other things of a similar kind;
the degree of excellence of service.
A more simple definition is to
Adherence to “Standard”
2
4. Critical Aspects During Audit (BABE)
Essential Elements of Quality Management
The quality policy must be clearly stated and drive should come
from management – “Quality Policy”
Required standards, guidelines understood and properly followed
– “Training”
System must be capable of preventing errors, emphasis on
prevention – “Preventive Action”
Independent assessment of compliance (measure the trend) –
“Trend of findings”
Flexible system (many regulations to follow)
State individual responsibilities clearly in quality management-
“Auditor- role and responsibility”
Adapted from the Qa in ba be (Mr. Prabhat Kumar) – link: https://www.slideshare.net/prabhugoa/qa-in-ba-be
4
5. Critical Aspects During Audit (BABE)
System must be capable of preventing errors, importance on prevention
Don’t Be a Traffic Police 5
Ref: image downloaded from presenter media
6. Critical Aspects During Audit (BABE)
Basic Variable
1. Man – “Employee”
2. Material
3. Method – “Operating Procedure”
4. Equipment
5. Environment
6
7. Critical Aspects During Audit (BABE)
Clinical QA
(GCP)
ICH (E6)
FDA, EMEA
Countries Regulation
(DCGI)
Bioanalytical QA
(GLP)
FDA, EMEA
OECD
Countries Regulation
Other’s
7
8. Critical Aspects During Audit (BABE)
Definitions Good Clinical Practice (GCP):
A standard for the design, conduct, performance ,
monitoring , auditing , recording, analyses, and reporting
of clinical trials that provides assurance that the data and
reported results are credible and accurate, and that the
rights, integrity, and confidentiality of trial subjects are
protected. [1.24, ICH Topic E6, GCP]
8
10. Critical Aspects During Audit (BABE)
What is Quality Assurance (QA)
All those planned and systematic actions that
are established to ensure that the trial is
performed and the data are generated,
documented (recorded), and reported in
compliance with Good Clinical Practice (GCP)
and the applicable regulatory requirement(s).
(1.46- ICH-GCP E6(R2))
10
11. Critical Aspects During Audit (BABE)
Trial Performed
Trial Data generated
Trial Data Recorded
Trial Data Reported
E
n
S
U
R
E
Compliance
with ?
Compliance
with ?
Compliance
with ?
E
n
S
U
R
E
11
12. Critical Aspects During Audit (BABE)
What is Audit?
A systematic and independent examination of trial
related activities and documents to determine
whether the evaluated trial related activities were
conducted, and the data were recorded, analyzed
and accurately reported according to the
protocol, sponsor's standard operating
procedures (SOPs), Good Clinical Practice (GCP),
and the applicable regulatory requirement(s).
(1.6 ICH-GCPE6(R2))
12
13. Conducted
Data were recorded
Data were analyzed
Trial related data
were accurately
reported
A
U
D
I
T
P
R
O
T
O
C
O
L
S
O
P
G
C
P
Systematic,
independent
P
R
O
T
O
C
O
L
S
O
P
G
C
P
G
C
P
13
14. Critical Aspects During Audit (BABE)
Case 01 – (For CR QA)- Protocol Compliance
Performed?
Data generated ?
Data recorded
accurately ?
Data reported
accurately ?
In-process audit- Actually screening was
performed?
Logbooks, Forms, computerized data, ECG, X-
ray films, (Source Data)
Screening Records, CRF
Clinical Study Report
14
15. Critical Aspects During Audit (BABE)
Case 01 – (For CR QA)- Protocol Compliance
Performed?
Data generated ?
Data recorded
accurately ?
Data reported
accurately?
Actually performed ?
Logbooks, Forms, CRF (Source Data)
CRF –section “Check-in details”, Meal
Records?
Clinical Study Report
15
16. Critical Aspects During Audit (BABE)
Case 01 – (For CR QA)- Protocol Compliance
Performed?
Data generated ?
Data recorded
accurately ?
Data reported
accurately?
Actually performed ?
Logbooks, Forms, CRF (Source Data)
BCR?
Clinical Study Report
16
17. Critical Aspects During Audit (BABE)
Case 01 – (For CR QA)- SOP Compliance
Performed?
Data generated ?
Data recorded
accurately ?
Data reported
accurately?
Actually performed ?
CRF (Source Data)
CRF
Clinical Study Report
17
18. Critical Aspects During Audit (BABE)
Case 01 – (For CR QA)- SOP Compliance
Performed?
Data generated ?
Data recorded
accurately ?
Data reported
accurately?
Actually performed by PI and CI only?
BCR (Source Data)
CRF-BCR- verified by sign?
Clinical Study Report
18
19. Critical Aspects During Audit (BABE)
Case 01 – (For BR QA)- SOP Compliance
Performed?
Data generated ?
Data recorded
accurately ?
Data reported
accurately?
Actually performed?
Forms, Logbook (Source Data)
Recorded by- Forms and
verified by ?
Analytical Study Report
19
20. Critical Aspects During Audit (BABE)
Case 01 – (For BR QA)-SOP Compliance
Performed?
Data generated ?
Data recorded
accurately ?
Data reported
accurately?
Actually performed?
Form, Logbook –Computer print-out
Forms, logbook ?
Analytical Study Report
20
21. Critical Aspects During Audit (BABE)
Case 01 – (For CR and BR QA)- GCP Compliance
Data generated ?
Data recorded
accurately ?
Data reported
accurately?
Approval Letter, In-house SOP forms
Forms, Logbook (if any)
Clinical Study Report
21
22. Critical Aspects During Audit (BABE)
Who is Auditor?
BABE study Generation of Data
Compliance as per GCP
22
Ref: image downloaded from presenter media and different regulatory sites, goggle images
Contract Research
Organization
23. Critical Aspects During Audit (BABE)
Role of Auditor
Confirm GxP (GCP,GLP) Compliance
Act as Catalyst for Quality Improvement
Provide Advice on GxP (GCP,GLP) matter
Provide training to research staff
To establish a quality and compliance based culture.
Maintained their own audit schedule
Plan audit is necessary
Aware of planned study
23
24. Critical Aspects During Audit (BABE)
Planned action
Planned activity?
•Study Plan ?
•System Audit Plan?
•Vendor Audit Plan ?
24
25. Critical Aspects During Audit (BABE)
Systematic action
Systematic action?
• Check-list?
• Execution of Audit?
• Systematic Follow-up findings closure?
• Every Documentation that QA does?
• Routes of Communication of findings ?
• Systematic Closure of deviation?
25
26. Critical Aspects During Audit (BABE)
Preparation of Audit
• Review of protocol, guideline, SOP, Past audit report
• Take sufficient time for audit (must be qualitative)
• Document every observation and findings.
• Every findings discussed with respective staff
• You should know about corrective action.
• Inform immediately about critical findings to HOD’s
Auditor should be prepared for audit by:
26
27. Critical Aspects During Audit (BABE)
Target the event
Target the Non-
compliance
Target the
Procedure
Don’t target
people
Target during
audit?
27
Ref: image downloaded from presenter media and different regulatory sites, goggle images
29. Critical Aspects During Audit (BABE)
Quality of Best Auditor
• Training expertise and experience
• Familiar with every SOP.
• In depth knowledge of applicable Guideline
• Eyes for details
• Understand the basic concept of underlying the
activity being monitored.
• To know what to do and why to do?
29
30. Critical Aspects During Audit (BABE)
What does QA do?
• Readiness of Site for external audit
• Internal processes are effectively implemented
• Data generated is valid and verified
• Check the whether study personnel are compliant with
their Role and responsibility?
• Duplication of work!
• Don’t forget “RIGHT”, “Safety” and “Well-being” of
subject
30
31. Critical Aspects During Audit (BABE)
You are the Part of QMS
• Anticipate the error- Audit all ways a process could fail
and make improvement to ensure it doesn't.
• Procedure- Developed clear system and procedure
• Training – Ensure every personnel are trained as per
their role.
• Validate- All operation must be validate
• Avoid Short cut: Follow the SOP’s.
• Challenge what you do? – Regularly check that
system meet applicable standard.
31
32. Critical Aspects During Audit (BABE)
Become the Best auditor
To read SOP, Guideline
To be professional
To be part of QMS
32
Ref: image downloaded from presenter media